615 related articles for article (PubMed ID: 23134073)
1. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
Woo YC; Xu A; Wang Y; Lam KS
Clin Endocrinol (Oxf); 2013 Apr; 78(4):489-96. PubMed ID: 23134073
[TBL] [Abstract][Full Text] [Related]
2. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
3. Metabolic actions of fibroblast growth factor 21.
Cuevas-Ramos D; Aguilar-Salinas CA; Gómez-Pérez FJ
Curr Opin Pediatr; 2012 Aug; 24(4):523-9. PubMed ID: 22732636
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases.
Cheung BM; Deng HB
Expert Rev Cardiovasc Ther; 2014 Jun; 12(6):659-66. PubMed ID: 24697521
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease.
Kralisch S; Fasshauer M
Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):354-9. PubMed ID: 21505329
[TBL] [Abstract][Full Text] [Related]
6. FGF21-based pharmacotherapy--potential utility for metabolic disorders.
Gimeno RE; Moller DE
Trends Endocrinol Metab; 2014 Jun; 25(6):303-11. PubMed ID: 24709036
[TBL] [Abstract][Full Text] [Related]
7. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
[TBL] [Abstract][Full Text] [Related]
9. FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs.
Kim KH; Lee MS
J Endocrinol; 2015 Jul; 226(1):R1-16. PubMed ID: 26116622
[TBL] [Abstract][Full Text] [Related]
10. FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting.
Liang Q; Zhong L; Zhang J; Wang Y; Bornstein SR; Triggle CR; Ding H; Lam KS; Xu A
Diabetes; 2014 Dec; 63(12):4064-75. PubMed ID: 25024372
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.
Li H; Fang Q; Gao F; Fan J; Zhou J; Wang X; Zhang H; Pan X; Bao Y; Xiang K; Xu A; Jia W
J Hepatol; 2010 Nov; 53(5):934-40. PubMed ID: 20675007
[TBL] [Abstract][Full Text] [Related]
12. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response.
Potthoff MJ; Inagaki T; Satapati S; Ding X; He T; Goetz R; Mohammadi M; Finck BN; Mangelsdorf DJ; Kliewer SA; Burgess SC
Proc Natl Acad Sci U S A; 2009 Jun; 106(26):10853-8. PubMed ID: 19541642
[TBL] [Abstract][Full Text] [Related]
13. DEPP/DEPP1/C10ORF10 regulates hepatic glucose and fat metabolism partly via ROS-induced FGF21.
Li W; Ji M; Lin Y; Miao Y; Chen S; Li H
FASEB J; 2018 Oct; 32(10):5459-5469. PubMed ID: 29702025
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.
Hotta Y; Nakamura H; Konishi M; Murata Y; Takagi H; Matsumura S; Inoue K; Fushiki T; Itoh N
Endocrinology; 2009 Oct; 150(10):4625-33. PubMed ID: 19589869
[TBL] [Abstract][Full Text] [Related]
15. A review of fibroblast growth factor 21 in diabetic cardiomyopathy.
Zhang X; Yang L; Xu X; Tang F; Yi P; Qiu B; Hao Y
Heart Fail Rev; 2019 Nov; 24(6):1005-1017. PubMed ID: 31175491
[TBL] [Abstract][Full Text] [Related]
16. Conjugated linoleic acid induces hepatic expression of fibroblast growth factor 21 through PPAR-α.
Yu J; Yu B; Jiang H; Chen D
Br J Nutr; 2012 Feb; 107(4):461-5. PubMed ID: 21767451
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
Mraz M; Bartlova M; Lacinova Z; Michalsky D; Kasalicky M; Haluzikova D; Matoulek M; Dostalova I; Humenanska V; Haluzik M
Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724
[TBL] [Abstract][Full Text] [Related]
18. Impact of FGF21 on glycemic control.
Strowski MZ
Horm Mol Biol Clin Investig; 2017 Jun; 30(2):. PubMed ID: 28593912
[TBL] [Abstract][Full Text] [Related]
19. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21.
Inagaki T; Dutchak P; Zhao G; Ding X; Gautron L; Parameswara V; Li Y; Goetz R; Mohammadi M; Esser V; Elmquist JK; Gerard RD; Burgess SC; Hammer RE; Mangelsdorf DJ; Kliewer SA
Cell Metab; 2007 Jun; 5(6):415-25. PubMed ID: 17550777
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 21 is induced by endoplasmic reticulum stress.
Schaap FG; Kremer AE; Lamers WH; Jansen PL; Gaemers IC
Biochimie; 2013 Apr; 95(4):692-9. PubMed ID: 23123503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
